BRIEF published on 09/22/2025 at 17:54, 2 months 12 days ago Societe Generale Progresses in Share Buy-Back Program Share Buy-back Euronext Paris Société Générale Market Abuse Regulation EUR 1 Billion
PRESS RELEASE published on 09/22/2025 at 17:49, 2 months 12 days ago Societe Generale: Information regarding executed transactions within the framework of a share buy-back program Societe Generale completes 71.8% of EUR 1 billion share buy-back program for shares cancellation as of 19 September 2025, under current regulations Société Générale Market Abuse Regulation Share Buy-back Program Regulations EUR 1 Billion
BRIEF published on 09/15/2025 at 17:53, 2 months 19 days ago Societe Generale's Share Buy-Back Progresses Share Buy-back Euronext Paris Société Générale Share Cancellation Market Regulation
PRESS RELEASE published on 09/15/2025 at 17:48, 2 months 19 days ago Societe Generale: Information regarding executed transactions within the framework of a share buy-back program Societe Generale provided details of executed transactions within a share buy-back program, complying with regulations. Purchases were conducted on various trading platforms Société Générale Share Buy-back Program Regulations Executed Transactions Trading Platforms
BRIEF published on 08/25/2025 at 17:51, 3 months 10 days ago Societe Generale Launches EUR 1 Billion Share Buyback Program Euronext Paris Société Générale Share Buyback Market Regulation EUR 1 Billion
PRESS RELEASE published on 08/25/2025 at 17:46, 3 months 10 days ago Societe Generale: Information regarding executed transactions within the framework of a share buyback program Societe Generale provides details of share buy-back program, completing 31.1% as of 22 August 2025, including purchases made on trading platforms Société Générale Financial Transactions Share Buy-back Program Market Regulation Trading Platforms
BRIEF published on 08/19/2025 at 17:50, 3 months 16 days ago Societe Generale: Shares and Voting Rights as of July 2025 Share Capital Voting Rights Société Générale Shares July 2025
PRESS RELEASE published on 08/19/2025 at 17:45, 3 months 16 days ago Societe Generale: shares & voting rights as of 31 July 2025 Societe Generale provides information on the number of shares composing the current share capital and total number of voting rights as of 31 July 2025, in accordance with regulatory requirements Voting Rights Société Générale Shares Regulatory Compliance French Corporation
BRIEF published on 08/11/2025 at 17:51, 3 months 24 days ago Societe Generale Commences Share Buy-Back Program Share Buy-back Société Générale Shareholder Value Financial Strategy Market Regulation
PRESS RELEASE published on 08/11/2025 at 17:46, 3 months 24 days ago Societe Generale: Information regarding executed transactions within the framework of a share buyback program Societe Generale commenced a EUR 1 billion share buy-back program, repurchasing 9.6% of shares as of 8 August 2025. Transactions details provided within regulatory framework Euronext Paris Société Générale Transactions Share Buy-back Program Regulation (EU) No 596/2014
Published on 12/05/2025 at 02:35, 3 hours 46 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 21 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 16 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 21 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 50 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 30 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 55 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 6 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 10 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 21 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 36 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 36 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 20 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
